Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Oct;59(10):1837-46.
doi: 10.1111/j.1532-5415.2011.03614.x. Epub 2011 Sep 13.

The feasibility of inpatient geriatric assessment for older adults receiving induction chemotherapy for acute myelogenous leukemia

Heidi D Klepin  1 , Ann M Geiger, Janet A Tooze, Stephen B Kritchevsky, Jeff D Williamson, Leslie R Ellis, Denise Levitan, Timothy S Pardee, Scott Isom, Bayard L Powell
Affiliations

The feasibility of inpatient geriatric assessment for older adults receiving induction chemotherapy for acute myelogenous leukemia

Heidi D Klepin et al. J Am Geriatr Soc. 2011 Oct.

Abstract

Objectives: To test the feasibility and utility of a bedside geriatric assessment (GA) to detect impairment in multiple geriatric domains in older adults initiating chemotherapy for acute myelogenous leukemia (AML).

Design: Prospective observational cohort study.

Setting: Single academic institution.

Participants: Individuals aged 60 and older with newly diagnosed AML and planned chemotherapy.

Measurements: Bedside GA was performed during inpatient exmination for AML. GA measures included the modified Mini-Mental State Examination; Center for Epidemiologic Studies Depression Scale; Distress Thermometer, Pepper Assessment Tool for Disability (includes self- reported activities of daily living (ADLs), instrumental ADLs, and mobility questions); Short Physical Performance Battery (includes timed 4-m walk, chair stands, standing balance); grip strength, and Hematopoietic Cell Transplantation Comorbidity Index.

Results: Of 54 participants (mean age 70.8 ± 6.4) eligible for this analysis, 92.6% completed the entire GA battery (mean time 44.0 ± 14 minutes). The following impairments were detected: cognitive impairment, 31.5%; depression, 38.9%; distress, 53.7%; impairment in ADLs, 48.2%; impaired physical performance, 53.7%; and comorbidity, 46.3%. Most were impaired in one (92.6%) or more (63%) functional domains. For the 38 participants rated as having good performance status according to standard oncologic assessment (Eastern Cooperative Oncology Performance Scale score ≤1), impairments in individual GA measures ranged from 23.7% to 50%. Significant variability in cognitive, emotional, and physical status was detected even after stratification according to tumor biology (cytogenetic risk group classification).

Conclusion: Inpatient GA was feasible and added new information to standard oncology assessment, which may be important for stratifying therapeutic risk in older adults with AML.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Proportion of older adults with acute myelogenous leukemia (AML) with deficits in up to four geriatric domains (psychological, cognitive, physical, comorbidity) at baseline (N = 54).
Figure 2
Figure 2
Proportion of older adults with acute myelogenous leukemia (AML) with impairments in geriatric assessment measures among the overall cohort and the subset with good oncology performance status (Eastern Cooperative Oncology Group (ECOG) Performance Status score ≤1). Figure displays results for participants with available ECOG scores; N = 52 for overall and N = 38 for ECOG ≤1 subsets.
See this image and copyright information in PMC

References

    1. [Accessed September 12, 2010];NCI Surveillance Epidimiology End Results [on-line] Available at http://seer.cancer.gov/statistics.
    1. Appelbaum FR, Gundacker H, Head DR, et al. Age and acute myeloid leukemia. Blood. 2006;107:3481–3485. - PMC - PubMed
    1. Lang K, Earle CC, Foster T, et al. Trends in the treatment of acute myeloid leukaemia in the elderly. Drugs Aging. 2005;22:943–955. - PubMed
    1. Menzin J, Lang K, Earle CC, et al. The outcomes and costs of acute myeloid leukemia among the elderly. Arch Intern Med. 2002;162:1597–1603. - PubMed
    1. Kantarjian H, O'brien S, Cortes J, et al. Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastic syndrome: Predictive prognostic models for outcome. Cancer. 2006;106:1090–1098. - PubMed

Publication types